We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.54B
AUM Growth
+$237M
Cap. Flow
-$26.5M
Cap. Flow %
-0.58%
Top 10 Hldgs %
16.93%
Holding
607
New
39
Increased
188
Reduced
275
Closed
42

Top Sells

Rank Stock Value
1
NWL icon
Newell Brands
NWL
+$16M
2
AGN
Allergan plc
AGN
+$15.1M
3
BFH icon
Bread Financial
BFH
+$14.7M
4
TECH icon
Bio-Techne
TECH
+$14M
5
DIS icon
Walt Disney
DIS
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 17.45%
2 Industrials 16.76%
3 Financials 14.5%
4 Technology 13.57%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSX icon
251
Phillips 66
PSX
$82.9B
$3.6M 0.08%
35,561
-1,575
-4% -$150K
AVGO icon
252
Broadcom
AVGO
$1.82T
$3.54M 0.08%
137,790
-4,030
-3% -$105K
BA icon
253
Boeing
BA
$165B
$3.44M 0.08%
11,661
-529
-4% -$143K
IWR icon
254
iShares Russell Mid-Cap ETF
IWR
$56.8B
$3.43M 0.08%
65,872
+7,316
+12% +$371K
OCLR
255
DELISTED
Oclaro Inc.
OCLR
$3.38M 0.07%
501,877
+231,612
+86% +$1.71M
SODA
256
DELISTED
SodaStream International Ltd
SODA
$3.34M 0.07%
47,500
+42,100
+780% +$2.79M
RTX icon
257
RTX Corp
RTX
$287B
$3.32M 0.07%
41,358
-139
-0.3% -$10.6K
BMY icon
258
Bristol-Myers Squibb
BMY
$127B
$3.11M 0.07%
50,772
-1,138
-2% -$71.2K
BRKR icon
259
Bruker
BRKR
$9.2B
$3.11M 0.07%
90,640
-24,661
-21% -$808K
KEYW
260
DELISTED
The KEYW Holding Corporation
KEYW
$3.1M 0.07%
+528,318
New +$3.31M
SMM
261
DELISTED
Salient Midstream & MLP Fund
SMM
$3.08M 0.07%
279,900
-22,750
-8% -$242K
WCN
262
Waste Connections
WCN
$42.8B
$3.06M 0.07%
43,170
-12,281
-22% -$858K
KO icon
263
Coca-Cola
KO
$354B
$3.06M 0.07%
66,677
-4,119
-6% -$189K
WHR icon
264
Whirlpool
WHR
$2.42B
$3.05M 0.07%
18,100
-2,430
-12% -$412K
CELG
265
DELISTED
Celgene Corp
CELG
$3.05M 0.07%
29,228
-4,087
-12% -$461K
VRNT
266
DELISTED
Verint Systems
VRNT
$2.98M 0.07%
139,876
+11,612
+9% +$250K
DVA icon
267
DaVita
DVA
$15.1B
$2.97M 0.07%
41,135
+3,980
+11% +$245K
OMC icon
268
Omnicom Group
OMC
$22.7B
$2.93M 0.06%
40,186
-1,251
-3% -$89.7K
SYK icon
269
Stryker
SYK
$127B
$2.85M 0.06%
18,414
-12,800
-41% -$1.95M
VWO icon
270
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$2.8M 0.06%
60,919
+2,759
+5% +$123K
HBIO icon
271
Harvard Bioscience
HBIO
$27.1M
$2.76M 0.06%
83,632
+7,431
+10% +$251K
ADI icon
272
Analog Devices
ADI
$181B
$2.74M 0.06%
30,810
-314
-1% -$27.8K
TXN icon
273
Texas Instruments
TXN
$255B
$2.7M 0.06%
25,811
+812
+3% +$79.1K
ECON icon
274
Columbia Emerging Markets Consumer ETF
ECON
$327M
$2.69M 0.06%
95,600
TRU icon
275
TransUnion
TRU
$14.8B
$2.67M 0.06%
48,667
+9,261
+24% +$493K

Similar funds

Segall Bryant & Hamill's Q4 2017 Portfolio in Review

As of Q4 2017, Segall Bryant & Hamill held 607 positions worth $4.54B, up 5.5% from $4.31B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Segall Bryant & Hamill's Q4 2017 filing shows 39 new, 188 increased, 275 reduced and 42 closed positions. Its largest new stake was Black Knight, Inc. Common Stock: 320,006 shares worth $14.1M. The largest sale was Newell Brands, an estimated $16M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q4 2017 buy was Black Knight, Inc. Common Stock: 320,006 shares worth $14.1M.
  • Segall Bryant & Hamill added most to FLIR Systems, Inc. (DE) Common Stock in Q4 2017, an estimated $46.2M increase.
  • Segall Bryant & Hamill's biggest Q4 2017 reduction was Newell Brands, cutting an estimated $16M.
  • Segall Bryant & Hamill fully exited Gigamon Inc. in Q4 2017, selling an estimated $8.49M.
  • Segall Bryant & Hamill's ten largest holdings make up 17% of its $4.54B portfolio in Q4 2017.
  • Segall Bryant & Hamill opened 39 new positions and closed 42 in Q4 2017.
  • Segall Bryant & Hamill's portfolio value rose 5.5% quarter-over-quarter to $4.54B.

Based on Segall Bryant & Hamill's 13F filing for Q4 2017, filed 15 Feb 2018.